Targeting the innate immune system in treating hepatitis B: prospects for functional cure
Chronic hepatitis B (CHB) infection remains a significant global public health concern. Functional cure, defined as hepatitis B surface antigen seroclearance with unquantifiable HBV DNA at 24 weeks off treatment, is a desirable endpoint in the treatment of CHB, yet challenging to achieve. Given the...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Korean Association for the Study of the Liver
2026-01-01
|
| Saila: | Clinical and Molecular Hepatology |
| Gaiak: | |
| Sarrera elektronikoa: | http://e-cmh.org/upload/pdf/cmh-2025-0935.pdf |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|